Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Cerilliant
Baxter
AstraZeneca
Chinese Patent Office
Mallinckrodt
Federal Trade Commission
Farmers Insurance
US Army
Citi

Generated: October 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 014684

« Back to Dashboard
NDA 014684 describes AVENTYL HYDROCHLORIDE, which is a drug marketed by Lilly and is included in one NDA. Additional details are available on the AVENTYL HYDROCHLORIDE profile page.

The generic ingredient in AVENTYL HYDROCHLORIDE is nortriptyline hydrochloride. There are eleven drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the nortriptyline hydrochloride profile page.

Summary for NDA: 014684

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrengthEQ 10MG BASE
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrengthEQ 25MG BASE
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Expired Orange Book Patents for NDA: 014684

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lilly
AVENTYL HYDROCHLORIDE
nortriptyline hydrochloride
CAPSULE;ORAL014684-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Lilly
AVENTYL HYDROCHLORIDE
nortriptyline hydrochloride
CAPSULE;ORAL014684-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Covington
Chinese Patent Office
Cerilliant
Accenture
Merck
Citi
Queensland Health
QuintilesIMS
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot